U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Minimal Reticulin Fibrosis of the Bone Marrow

MedGen UID:
269238
•Concept ID:
C1513313
•
Finding

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVMinimal Reticulin Fibrosis of the Bone Marrow

Professional guidelines

PubMed

Bone marrow fibrosis in childhood acute lymphoblastic leukemia correlates to biological factors, treatment response and outcome.
Norén-Nyström U, Roos G, Bergh A, Botling J, Lönnerholm G, Porwit A, Heyman M, Forestier E
Leukemia 2008 Mar;22(3):504-10. Epub 2007 Dec 20 doi: 10.1038/sj.leu.2405072. PMID: 18094715
Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosis.
Thiele J, Kvasnicka HM, Zankovich R, Diehl V
Ann Hematol 2001 Mar;80(3):160-5. doi: 10.1007/s002770000278. PMID: 11320901

Recent clinical studies

Etiology

Risk evaluation and mitigation strategies (REMS): educating the prescriber.
Nicholson SC, Peterson J, Yektashenas B
Drug Saf 2012 Feb 1;35(2):91-104. doi: 10.2165/11597840-000000000-00000. PMID: 22171604
Romiplostim: a novel thrombopoiesis-stimulating agent.
Perreault S, Burzynski J
Am J Health Syst Pharm 2009 May 1;66(9):817-24. doi: 10.2146/ajhp080524. PMID: 19386944
Bone marrow fibrosis in childhood acute lymphoblastic leukemia correlates to biological factors, treatment response and outcome.
Norén-Nyström U, Roos G, Bergh A, Botling J, Lönnerholm G, Porwit A, Heyman M, Forestier E
Leukemia 2008 Mar;22(3):504-10. Epub 2007 Dec 20 doi: 10.1038/sj.leu.2405072. PMID: 18094715
Therapy-related changes of the bone marrow in chronic idiopathic myelofibrosis.
Thiele J, Kvasnicka HM, Schmitt-Gräff A, Hülsemann R, Diehl V
Histol Histopathol 2004 Jan;19(1):239-50. doi: 10.14670/HH-19.239. PMID: 14702192
The value of bone marrow biopsy in the prognosis of hairy cell leukemia (HCL).
Podzimek K, Kerekes Z, Chrobák L, Skalská H, Voglová J, Mirová S, Dulícek P, Zák P
Neoplasma 1994;41(6):325-30. PMID: 7870215

Diagnosis

Bone marrow fibrosis in childhood acute lymphoblastic leukemia correlates to biological factors, treatment response and outcome.
Norén-Nyström U, Roos G, Bergh A, Botling J, Lönnerholm G, Porwit A, Heyman M, Forestier E
Leukemia 2008 Mar;22(3):504-10. Epub 2007 Dec 20 doi: 10.1038/sj.leu.2405072. PMID: 18094715
Myelofibrosis in chronic myeloproliferative disorders--dynamics and clinical impact.
Thiele J, Kvasnicka HM
Histol Histopathol 2006 Dec;21(12):1367-78. doi: 10.14670/HH-21.1367. PMID: 16977587
Therapy-related changes of the bone marrow in chronic idiopathic myelofibrosis.
Thiele J, Kvasnicka HM, Schmitt-Gräff A, Hülsemann R, Diehl V
Histol Histopathol 2004 Jan;19(1):239-50. doi: 10.14670/HH-19.239. PMID: 14702192
Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosis.
Thiele J, Kvasnicka HM, Zankovich R, Diehl V
Ann Hematol 2001 Mar;80(3):160-5. doi: 10.1007/s002770000278. PMID: 11320901
The value of bone marrow biopsy in the prognosis of hairy cell leukemia (HCL).
Podzimek K, Kerekes Z, Chrobák L, Skalská H, Voglová J, Mirová S, Dulícek P, Zák P
Neoplasma 1994;41(6):325-30. PMID: 7870215

Therapy

Romiplostim: a novel thrombopoiesis-stimulating agent.
Perreault S, Burzynski J
Am J Health Syst Pharm 2009 May 1;66(9):817-24. doi: 10.2146/ajhp080524. PMID: 19386944
Therapy-related changes of the bone marrow in chronic idiopathic myelofibrosis.
Thiele J, Kvasnicka HM, Schmitt-Gräff A, Hülsemann R, Diehl V
Histol Histopathol 2004 Jan;19(1):239-50. doi: 10.14670/HH-19.239. PMID: 14702192
Bone marrow histopathology following cytoreductive therapy in chronic idiopathic myelofibrosis.
Thiele J, Kvasnicka HM, Schmitt-Graeff A, Diehl V
Histopathology 2003 Nov;43(5):470-9. doi: 10.1046/j.1365-2559.2003.01732.x. PMID: 14636273

Prognosis

Bone marrow fibrosis in childhood acute lymphoblastic leukemia correlates to biological factors, treatment response and outcome.
Norén-Nyström U, Roos G, Bergh A, Botling J, Lönnerholm G, Porwit A, Heyman M, Forestier E
Leukemia 2008 Mar;22(3):504-10. Epub 2007 Dec 20 doi: 10.1038/sj.leu.2405072. PMID: 18094715
Myelofibrosis in chronic myeloproliferative disorders--dynamics and clinical impact.
Thiele J, Kvasnicka HM
Histol Histopathol 2006 Dec;21(12):1367-78. doi: 10.14670/HH-21.1367. PMID: 16977587
Therapy-related changes of the bone marrow in chronic idiopathic myelofibrosis.
Thiele J, Kvasnicka HM, Schmitt-Gräff A, Hülsemann R, Diehl V
Histol Histopathol 2004 Jan;19(1):239-50. doi: 10.14670/HH-19.239. PMID: 14702192
Evolution of fibro-osteosclerotic bone marrow lesions in primary (idiopathic) osteomyelofibrosis--a histomorphometric study on sequential trephine biopsies.
Thiele J, Chen YS, Kvasnicka HM, Diehl V, Fischer R
Leuk Lymphoma 1994 Jun;14(1-2):163-9. doi: 10.3109/10428199409049664. PMID: 7920225
The value of bone marrow biopsy in the prognosis of hairy cell leukemia (HCL).
Podzimek K, Kerekes Z, Chrobák L, Skalská H, Voglová J, Mirová S, Dulícek P, Zák P
Neoplasma 1994;41(6):325-30. PMID: 7870215

Clinical prediction guides

The stromal composition of mast cell aggregates in systemic mastocytosis.
Chiu A, Nanaji NM, Czader M, Gheorghe G, Knowles DM, Chadburn A, Orazi A
Mod Pathol 2009 Jul;22(7):857-65. Epub 2009 Apr 24 doi: 10.1038/modpathol.2009.53. PMID: 19396155
Myelofibrosis in chronic myeloproliferative disorders--dynamics and clinical impact.
Thiele J, Kvasnicka HM
Histol Histopathol 2006 Dec;21(12):1367-78. doi: 10.14670/HH-21.1367. PMID: 16977587
Bone marrow histopathology following cytoreductive therapy in chronic idiopathic myelofibrosis.
Thiele J, Kvasnicka HM, Schmitt-Graeff A, Diehl V
Histopathology 2003 Nov;43(5):470-9. doi: 10.1046/j.1365-2559.2003.01732.x. PMID: 14636273
Evolution of fibro-osteosclerotic bone marrow lesions in primary (idiopathic) osteomyelofibrosis--a histomorphometric study on sequential trephine biopsies.
Thiele J, Chen YS, Kvasnicka HM, Diehl V, Fischer R
Leuk Lymphoma 1994 Jun;14(1-2):163-9. doi: 10.3109/10428199409049664. PMID: 7920225
The value of bone marrow biopsy in the prognosis of hairy cell leukemia (HCL).
Podzimek K, Kerekes Z, Chrobák L, Skalská H, Voglová J, Mirová S, Dulícek P, Zák P
Neoplasma 1994;41(6):325-30. PMID: 7870215

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...